SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.67-0.8%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Howard Bennett who wrote (435)1/5/1998 6:23:00 PM
From: AllenP  Read Replies (1) of 9523
 
More news:

Monday January 5, 2:48 am Eastern Time
UK's Peptide Therap , Pfizer sign deal
LONDON, Jan 5 (Reuters) - British vaccines specialist Peptide Therapeutics Group Plc said on Monday it would collaborate with U.S. pharmaceutical group Pfizer Inc for development of a veterinary allergy vaccine.
According to the deal, the vaccine will be developed initially for prevention of dermatitis in dogs caused by allergy to flea bites.

Pfizer will conduct and pay all costs of the research and clinical development programme for evaluating the vaccine.

The U.S. company has acquired an exclusive option to a worldwide licence for the vaccine.

Peptide Therapeutics had signed an alliance with British pharmaceutical company SmithKline Beecham Plc (quote from Yahoo! UK & Ireland: SB.L) last year for developing a human allergy vaccine.

--------------------------------------------------------------------------------
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext